Technology News and Research

RSS

FDA, Agilent partner to develop new tools for detection of salmonella subtypes

Agilent Technologies Inc. today announced that it has entered into a Cooperative Research and Development Agreement with the U.S. Food and Drug Administration to develop new tools to detect and analyze pathogens in food.

20 Mar 2012

Former premature infants to celebrate 25th anniversary of LUHS' NICU on March 20

Former premature infants will return to celebrate the 25th anniversary of Loyola University Health System's (LUHS) neonatal intensive care unit (NICU) at 11 a.m. on Tuesday, March 20. These patients are among the more than 18,000 infants who have been cared for by LUHS doctors and nurses since the unit opened its doors in 1987.

20 Mar 2012

Tyler Prize for Environmental Achievement honors two experts on air pollution

Tyler Prize for Environmental Achievement honors two experts on air pollution with the 2012 Tyler Prize for their work to advance the scientific understanding of air pollution, and develop solutions to reduce the danger to human health and the impact on climate change.

20 Mar 2012

Tobii completes USD $21 million funding round

Tobii Technology, the global leader in eye tracking and gaze interaction, announced today that it has closed a USD $21M funding round. New investor Intel Capital joins existing investors Amadeus Capital, Investor Growth Capital and Northzone Ventures.

20 Mar 2012

Benvenue Medical initiates enrollment in Luna Interbody System for Fusion Trial

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced that it has actively started enrolling patients in the Luna Interbody System for Fusion Trial.

20 Mar 2012

Heptares exercises exclusive option to license new A2A antagonist for CNS disorders

Heptares Therapeutics, the leading GPCR drug discovery company, announces that an operating company of Shire PLC, the global specialty biopharmaceutical company, has exercised its exclusive option to license a novel adenosine A2A antagonist discovered by Heptares that is currently in preclinical development.

20 Mar 2012

Otolaryngology-Head and Neck Surgery publishes new sudden hearing loss guideline

The first national treatment guideline for sudden hearing loss, a frightening condition that sends thousands in the U.S. to the emergency room each year, was published this month in the journal Otolaryngology-Head and Neck Surgery.

20 Mar 2012

Synthes signs license and development agreement with Kuros

Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications has signed a license and development agreement with Synthes, Inc. a leading global medical device company.

20 Mar 2012

U.S. Senator from Texas receives NSBRI's Pioneer Award

In recognition of her ongoing support of the nation's human spaceflight program, U.S. Senator Kay Bailey Hutchison is the 2012 recipient of the National Space Biomedical Research Institute's (NSBRI) Pioneer Award.

20 Mar 2012

Researchers discover new method to identify cancer-causing translocations

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah report they have discovered a method to identify cancer-causing rearrangements of genetic material called chromosomal translocations quickly, accurately, and inexpensively.

20 Mar 2012

Health must be taken into account in climate change mitigation strategies

Health must be taken into account in climate change mitigation strategies. It is not widely appreciated that there are many benefits to health that are likely to accrue from a low carbon economy, say experts in a special supplement published on bmj.com today.

20 Mar 2012

Moraga announces publication of its blood-derived BLSCs patent with EPO

Moraga Biotechnology Corporation, an adult stem cell company based in Culver City, California, announces the publication of its blood-derived Blastomere-Like Stem Cells (BLSCs) patent with the European Patent Office.

20 Mar 2012

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms worsen and then improve.

19 Mar 2012

TriZetto QNXT Essentials solution to streamline administration of Ventura County's HMO

Ventura County, Calif., has selected The TriZetto Group, Inc., to help improve the administrative efficiency, care delivery, and provider and member service of the county's health plan. TriZetto's end-to-end solution will streamline the administration of Ventura County's HMO, which serves employees and their families, retirees, Medicare recipients, and county-affiliated organizations.

19 Mar 2012

Ingenuity Variant Analysis and iReport selected for Weill Cornell sequencing core facility

Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced that the Weill Cornell Medical College has chosen Ingenuity Variant Analysis and Ingenuity iReport for use in its sequencing core facility.

19 Mar 2012

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

MabCure Inc., leading developer of antibody based technology for the diagnosis and treatment of Ovarian, Prostate, Colorectal and other cancers today announced it has entered into an agreement with the City University of New York Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.

19 Mar 2012

DNA Electronics licenses technology platform for rapid, lab-free DNA detection to geneOnyx

DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that it has licensed its ground-breaking Genalysis technology platform for rapid, lab-free DNA detection to geneOnyx, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.

19 Mar 2012

NIH awards Avaxia $1.5M Phase II SBIR grant to develop antibody therapeutic for IBD

Avaxia Biologics, Inc., a privately-held biotech company using its proprietary platform technology to develop orally-active antibody therapeutics for the treatment of gastrointestinal diseases, is proud to announce that it has received a second round of funding from the National Institutes of Health for its work in inflammatory bowel disease.

19 Mar 2012

New medical education portal - Lipoprotein Perspectives - launched

LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) technology, announced the launch of Lipoprotein Perspectives - a medical education portal featuring experts in clinical and preventive cardiology, endocrinology, and lipidology - at www.lipoprotein.org.

19 Mar 2012

CoActiv Medical, Capital X-Ray enter distribution agreement

CoActiv Medical, the PACS, RIS and cloud-based digital archiving innovator, announces a distribution agreement with Capital X-Ray, the largest independent x-ray dealer in the Southeast. Under the new agreement, CXR will distribute the complete CoActiv product line in Mississippi, Alabama, Georgia and the Florida panhandle.

19 Mar 2012

Technology News and Research

FDA, Agilent partner to develop new tools for detection of salmonella subtypes

Former premature infants to celebrate 25th anniversary of LUHS' NICU on March 20

Tyler Prize for Environmental Achievement honors two experts on air pollution

Tobii completes USD $21 million funding round

Benvenue Medical initiates enrollment in Luna Interbody System for Fusion Trial

Heptares exercises exclusive option to license new A2A antagonist for CNS disorders

Otolaryngology-Head and Neck Surgery publishes new sudden hearing loss guideline

Synthes signs license and development agreement with Kuros

U.S. Senator from Texas receives NSBRI's Pioneer Award

Researchers discover new method to identify cancer-causing translocations

Health must be taken into account in climate change mitigation strategies

Moraga announces publication of its blood-derived BLSCs patent with EPO

Gilenya - pill for relapsing-remitting multiple sclerosis recommended by NICE

TriZetto QNXT Essentials solution to streamline administration of Ventura County's HMO

Ingenuity Variant Analysis and iReport selected for Weill Cornell sequencing core facility

MabCure, CUNY CAT partner to evaluate monoclonal antibodies against ovarian cancer cells

DNA Electronics licenses technology platform for rapid, lab-free DNA detection to geneOnyx

NIH awards Avaxia $1.5M Phase II SBIR grant to develop antibody therapeutic for IBD

New medical education portal - Lipoprotein Perspectives - launched

CoActiv Medical, Capital X-Ray enter distribution agreement

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News